Why is "Amikacin" trending?

Search Interest Perspective

• Synergistic effects of meropenem, amikacin, and ciprofloxacin against carbapenem resistant Pseudomonas aeruginosa isolates | Scientific Reports - Nature
• Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease - Insmed Incorporated Investor Relations
• From Needle to Sachet: Fosfomycin Versus Amikacin for Cystoscopy Prophylaxis - Cureus
• Positive Ph3 Arikayce Data for MAC Lung Disease - respiratory-therapy.com
• Challenges and Efficacy of Amikacin Liposome Inhalation in Real-World Refractory Mycobacterium avium Complex Pulmonary Disease - Cureus
• Stride Toward Healing: Groundbreaking foal research sheds light on joint infection treatments - news.okstate.edu
• Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia - NEJM
• Administration Method Does Not Affect Antibiotic Levels After IVRLP - EquiManagement
• New data could make Insmed's MAC lung disease drug a frontline contender - FirstWord Pharma
• Chitosan-encapsulated Aloe vera nanoparticles outperform carrier-free forms in enhancing MSCs therapy for amikacin nephrotoxicity - Nature
• Does Prolonged IV Amikacin Therapy Improve Outcomes in M Abscessus? - Pulmonology Advisor
• Inhaled Amikacin Reduces Burden of Ventilator-Associated Pneumonia - Infectious Disease Advisor
• Evaluation of In Vitro Effects of Fosfomycin in Combination With Amikacin and Ciprofloxacin Against Multidrug-Resistant Escherichia coli Isolates - Cureus
• Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update - Insmed Incorporated Investor Relations
• Molecular basis of the pleiotropic effects by the antibiotic amikacin on the ribosome - Nature
• Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae - Nature
• Synergistic antibacterial activity of ceftazidime–avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae | Scientific Reports - Nature
• Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports - Nature
• Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin - Frontiers
• Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates - Nature
• Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility - Nature
• The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection - Wiley Online Library
• Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis - Frontiers
• The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection - ASM Journals
• Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia - NEJM
• Amikacin Plus Standard of Care Does Not Improve Survival in Gram-Negative Pneumonia - Pulmonology Advisor
• Low-Dose Amikacin as Alternative Treatment for Multidrug-Resistant Tuberculosis - Infectious Disease Advisor
• Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter-related infection treated with amikacin - Wiley Online Library
• Amikacin and bacteriophage treatment modulates outer membrane proteins composition in Proteus mirabilis biofilm - Nature
• Antibacterial Activity of Bismuth Oxide Nanoparticles Compared to Amikacin against Acinetobacter baumannii and Staphylococcus aureus - Wiley Online Library
• Laryngitis after inhalation of liposomal amikacin - Morita - 2022 - Clinical Case Reports - Wiley Online Library
• Amikacin prevents ventilator-associated pneumonia in mechanically ventilated patients - 2 Minute Medicine
• Amikacin safe, improves respiratory symptoms in M. avium complex lung disease - Healio
• Dynamics and quantitative contribution of the aminoglycoside 6′- N -acetyltransferase type Ib to amikacin resistance - ASM Journals
• Amikacin and Equine Chondrocytes - EquiManagement
• Inhibition of aac(6′)-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria - PNAS
• Effects of combinations of clindamycin with gentamicin, tobramycin, and amikacin against Staphylococcus aureus - Oxford Academic
• Successful Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease With Sitafloxacin After Failed Amikacin Liposome Inhalation Suspension Therapy - Cureus
• Amikacin Liposome Inhalation Suspension to Treat M Abscessus Pulmonary Disease - Pulmonology Advisor
• Are Fluoroquinolones Synergistic in Combination With Vancomycin, Amikacin, and Ceftazidime? Possible Implication in Treatment of Bacterial Endophthalmitis | IOVS | ARVO Journals - ARVO Journals
• Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa - Frontiers
• Reconsider Amikacin at Reduced Doses for Joint Injections - thehorse.com
• Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch - Insmed Incorporated Investor Relations
• Cystic Fibrosis: Nebulized Manuka Honey Improved Bacterial Clearance - respiratory-therapy.com
• INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC - PR Newswire
• Inhaled amikacin lowers incidence of ventilator-associated pneumonia - Healio
• Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 Inte - Insmed Incorporated Investor Relations
• Coordination Polymer as a Self-Calibrated pH and Amikacin Luminescence Probe - ACS Publications
• Biodistribution of Amikacin Solid Lipid Nanoparticles after Pulmonary Delivery - Wiley Online Library
• Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates - Frontiers
• Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients - Oxford Academic
• Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae - Frontiers
• New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patients with Refractory MAC Lung Disease - PR Newswire
• Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with MAC Lung Disease - PR Newswire
• Amikacin dosage in the preterm newborn - Oxford Academic
• The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation | The Journal of Antibiotics - Nature
• Joint Injections and IA Antimicrobials in Horses - thehorse.com
• ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR - Insmed Incorporated Investor Relations
• New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease - PR Newswire
• FDA Approves Amikacin Liposome Inhalation Suspension for Lung Disease Caused by MAC Bacteria - HCPLive
• Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus - Oxford Academic
• Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia - Oxford Academic
• Experimental and Therapeutic Medicine - Spandidos Publications
• ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR - PR Newswire
• Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients - Nature
• Trial: Inhaled preventive antibiotic reduces risk of ventilator-associated pneumonia - CIDRAP
• Inhaled amikacin reduces ventilatory-associated pneumonia - Medical Xpress
• Manuka honey could help to clear deadly drug-resistant lung infection – research - EurekAlert!
• Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global Patent Portfolio - PR Newswire
• Postoperative Nocardia Endophthalmitis and the Challenge of Managing with Intravitreal Amikacin - Wiley Online Library
• The role of doxycycline in the therapy of multidrug-resistant E. coli – an in vitro study - Nature
• Microbial Growth Prompts Recall of Two Injectable Drugs - Infectious Disease Advisor
• PANTHERx® Specialty Pharmacy Selected by Insmed to Distribute ARIKAYCE® (amikacin liposome inhalation suspension) - PR Newswire
• Intravesical Therapies for Recurrent Urinary Tract Infections: A Systematic Review - Cureus
• Evaluation of Antimicrobial Activity of Intravitreal Antibiotics After Prolonged Storage - ARVO Journals
• Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways - ScienceDirect.com
• Teva Launches Generic Amikin Injection - Medical Professionals Reference
• Survey: Management of Amikacin Liposome Inhalation Suspension-Associated Respiratory Adverse Events - Medical Professionals Reference
• Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a result of a sterility test failure - PR Newswire
• Inhaled Amikacin Shows Promise for Untreated MAC Lung Infections - MedPage Today
• LAMIRA®, an eFlow® Technology nebulizer, expected to launch in Japan as a medical device for exclusive administration of ARIKAYCE® (amikacin liposome inhalation suspension) - BioSpace
• Amikacin prevents ventilator-associated pneumonia in mechanically ventilated patients - 2 Minute Medicine
• CDSCO Flags 74 Drugs, Devices Samples as NSQ in December: Zerodol-SP, Defcort, Telmisartan, Amikacin... - Medical Dialogues
• Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update - Insmed Incorporated Investor Relations
• A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of Concept - Frontiers
• An in vitro study on the compatibility and concentrations of combinations of vancomycin, amikacin, and dexamethasone in human vitreous - Nature
• Pharmacokinetics of aerosolized amikacin assessed in patients with impaired renal function - BioWorld News
• Antibiotic resistance pattern of Klebsiella pneumoniae in obtained samples from Ziaee Hospital of Ardakan, Yazd, Iran during 2016 to 2017 - SciELO España
• Nontuberculous Mycobacterial Infection After Cholecystectomy: A Case Series and Literature Review - Cureus
• Arikayce Nets $21M in First 6 Months Treating MAC Lung Disease - respiratory-therapy.com
• PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) - PR Newswire
• Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro - Oxford Academic
• Arikayce Approved to Treat Mycobacterium Avium Complex Lung Disease - Medical Professionals Reference
• Retention of antibiotic activity against resistant bacteria harbouring aminoglycoside- N -acetyltransferase enzyme by adjuvants: a combination of in-silico and in-vitro study - Nature
• Manuka Honey Can Be Used to Inhibit Drug-Resistant Mycobacteria: Study - Sci.News
• Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with Granulocytopenia - NEJM
• LAMIRA®, an eFlow® Technology nebulizer, expected to launch in Japan as a medical device for exclusive administration of ARIKAYCE® (amikacin liposome inhalation suspension) - PR Newswire
• Amikacin/Ampicillin: Combo of Choice for Septic Foals - thehorse.com
• Equine Regional Limb Perfusion - EquiManagement
• Bayer drug-device combo for pneumonia flunks phase III test - PMLiVE